This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thomas, S. Articles by Shah, G. Search for Related Content PubMed PubMed Citation Articles by Thomas, S. Articles by Shah, G.

Calcitonin Increases Tumorigenicity of Prostate Cancer Cells: Evidence for the Role of Protein Kinase A and Urokinase-Type Plasminogen Receptor

Pharmacology, University of Louisiana College of Pharmacy, Monroe, Louisiana 71209

Address all correspondence and requests for reprints to: Girish V. Shah, Ph.D., Department of Pharmacology, College of Pharmacy, University of Louisiana, 700 University Avenue, Monroe, Louisiana 71209. E-mail: shah{at}ulm.edu.

The expression of human (h) calcitonin (CT) and its receptor (CTR) is localized to basal epithelium in benign prostates but is distributed in whole epithelium of malignant prostates. Moreover, the abundance of hCT and CTR mRNA in primary prostate tumors positively correlates with the tumor grade. We tested the hypothesis that the modulation of endogenous hCT expression of prostate cancer (PC) cell lines alters their oncogenicity. The effect of modulation of hCT expression on oncogenic characteristics was examined in LNCaP and PC-3M cell lines. The endogenous hCT expression was modulated using either constitutively active expression vector containing hCT cDNA or anti-hCT hammerhead ribozymes. The changes in the oncogenicity of cell sublines was assessed with cell proliferation assays, invasion assays, colony formation assays, and in vivo growth in athymic nude mice. Up-regulation of hCT in PC-3M cells and or enforced hCT expression in LNCaP cells dramatically enhanced their oncogenic characteristics. In contrast, the down-regulation of hCT in PC-3M cells led to a dramatic decline in their oncogenicity. These results, when combined with our other results, that the expression of hCT in primary PCs increase with tumor grade, suggest an important role for hCT in the progression of PC to a metastatic phenotype.

This article has been cited by other articles:

				Y. Zhong, H. J. Armbrecht, and S. Christakos Calcitonin, a Regulator of the 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Gene J. Biol. Chem., April 24, 2009; 284(17): 11059 - 11069. [Abstract] [Full Text] [PDF]

				G. V. Shah, A. Muralidharan, S. Thomas, M. Gokulgandhi, M. Mudit, M. Khanfar, and K. El Sayed Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis Mol. Cancer Ther., March 1, 2009; 8(3): 509 - 520. [Abstract] [Full Text] [PDF]

				G. V. Shah, A. Muralidharan, M. Gokulgandhi, K. Soan, and S. Thomas Cadherin Switching and Activation of {beta}-Catenin Signaling Underlie Proinvasive Actions of Calcitonin-Calcitonin Receptor Axis in Prostate Cancer J. Biol. Chem., January 9, 2009; 284(2): 1018 - 1030. [Abstract] [Full Text] [PDF]

				G. V Shah, S. Thomas, A. Muralidharan, Y. Liu, P. L Hermonat, J. Williams, and J. Chaudhary Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways Endocr. Relat. Cancer, December 1, 2008; 15(4): 953 - 964. [Abstract] [Full Text] [PDF]

				M. Nakamura, B. Han, T. Nishishita, Y. Bai, and K. Kakudo Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers J. Mol. Endocrinol., December 1, 2007; 39(6): 375 - 384. [Abstract] [Full Text] [PDF]